Mediwound Stock Investor Sentiment

MDWD Stock  USD 17.33  0.85  5.16%   
About 55% of Mediwound's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Mediwound stock suggests that some investors are interested at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at finance.yahoo.com         
Wound Care Market Research Report 2018-2032 Industry Size, Shares, Acquisitions, Recent Developments...
Yahoo News
over two months ago at news.google.com         
TD Cowen maintains Buy rating on MediWound shares with no price target change - Investing.com
Google News at Macroaxis
over two months ago at news.google.com         
MediWound Stock Price Crosses Below 200-Day Moving Average of 16.99 - MarketBeat
Google News at Macroaxis
over two months ago at finance.yahoo.com         
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Yahoo News
over two months ago at seekingalpha.com         
MediWound files to sell 1.45M ordinary shares for holders
seekingalpha News
over three months ago at finance.yahoo.com         
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
Yahoo News
over three months ago at finance.yahoo.com         
MediWound Ltd.s top owners are retail investors with 38 percent stake, while 28 percent is held by i...
Yahoo News
over three months ago at news.google.com         
MDWD - MediWound Ltd. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at seekingalpha.com         
MediWound receives pediatric indication for burn treatment NexoBrid
seekingalpha News
over three months ago at simplywall.st         
MediWound Second Quarter 2024 Earnings EPS Misses Expectations
Simply Wall St News at Macroaxis
over three months ago at benzinga.com         
MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid for the Treatment of Pedi...
benzinga news
over three months ago at gurufocus.com         
MediWound Ltd Q2 2024 Earnings Call Transcript Highlights Revenue Growth Amidst ...
Gurufocus Stories at Macroaxis
over three months ago at investing.com         
Earnings call MediWound reports robust Q2 results, expands NexoBrid reach
Investing News at Macroaxis
over three months ago at finance.yahoo.com         
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Therm...
Yahoo News
over three months ago at finance.yahoo.com         
MediWound Reports Q2 Loss, Lags Revenue Estimates
Yahoo News
Far too much social signal, news, headlines, and media speculation about Mediwound that are available to investors today. That information is available publicly through Mediwound media outlets and privately through word of mouth or via Mediwound internal channels. However, regardless of the origin, that massive amount of Mediwound data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Mediwound news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mediwound relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mediwound's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mediwound alpha.

Mediwound Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
09/03/2024
2
Wound Care Market Research Report 2018-2032 Industry Size, Shares, Acquisitions, Recent Developments, Takeaways by Sector
10/04/2024
3
Xencor Reports Q3 Loss, Tops Revenue Estimates
11/06/2024
4
Durect Reports Q3 Loss, Misses Revenue Estimates
11/13/2024
5
MediWound Q3 2024 Earnings Preview
11/25/2024

Complementary Tools for Mediwound Stock analysis

When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stocks Directory
Find actively traded stocks across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance